MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) sold 12.3% of their position (1.54K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $799.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/7/2026ACC: 0000875320-26-000243
Officer· EVP, Chief Commercial Officer
Since Mar 2026
-1.54K
Net shares
Net seller
$799.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.54K
Price / share
$519.00
Trade value
$799.78K
% of position
12.3%
7/2/2026
12.54K→11K
Total
Net shares
−1.54K
Net value
-$799.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/2/2026 | S · Sale | −1.54K | $519.00 | $799.78K | 12.3% | 12.54K | 11K |
| Total | −1.54K | -$799.78K | ||||||
Derivative Transactions0
No derivative transactions reported